To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
58 Current news about the topic gene silencing
rss
Dharmacon RNAi Technology Selected by Genentech to support Drug Discovery Research
07-02-2005
Dharmacon, Inc. announced that Genentech, Inc. has selected Dharmacon's advanced RNAi technology for use in its drug discovery and development research. Under an agreement between the two companies, Dharmacon will supply Genentech with a range of siRNA reagents including Dharmacon's Human ...
Study: Target Specificity is Primary Focus of Research in RNAi Technologies
13-12-2004
While ribonucleic acid interference (RNAi) offers a fresh approach to drug discovery, validation, and delivery, current research efforts gears toward improving target specificity. In this regard, scientists are giving top priority to finding the most efficient means to deliver or transfect ...
Fraunhofer Biotech-Enhanced Plant Growth to be Commercialized by Delaware Research Center
20-10-2004
IP2Revenues LLC (IP2R), an Intellectual Property Commercialization & Licensing company, has signed a contract with the Fraunhofer USA Center for Molecular Biotechnology (FhCMB) to expedite commercialization of a proprietary technology developed by Fraunhofer. "We're very excited about this ...
atugen and Aventis to collaborate in identifying siRNA compounds with the potential for therapeutic development
16-09-2004
Berlin. atugen AG announced that it has signed a collaboration agreement with Aventis to identify siRNA compounds with the potential for therapeutic development. It is planned to combine atugen's proprietary siRNA (short-interfering RNA) technology and expertise in gene silencing with ...
Dharmacon and Genospectra to Launch Genome-Wide Line of Novel RNA Assays for Gene Silencing Measurement
26-07-2004
Dharmacon, Inc., the world's leading supplier of innovative RNA and RNA interference (RNAi) research products, and Genospectra, Inc., the exclusive supplier of QuantiGene(R) branched DNA (bDNA) gene expression profiling technology, announced an agreement to launch a genome-wide line of ...
Study about World RNAi Markets: Current and Future Outlook
20-07-2004
From being a molecular novelty, ribonucleicacid (RNA) interference (RNAi) has swiftly become the focus area of biotechnology and pharmaceutical companies. RNAi is, today, regarded as a breakthrough technology platform for applications in research, target validation and therapeutics. One ...
atugen and Sankyo Sign Multi-Year Contract Research Agreement
20-05-2004
Berlin, Germany. atugen AG announced that it has signed a multi-year contract research agreement with Sankyo Co. Ltd, one of Japan's leading pharmaceutical companies. Both companies have already successfully collaborated on a number of proprietary molecular targets that Sankyo has discovered ...
QIAGEN Launches Comprehensive Human siRNA Library Sets
05-05-2004
Venlo, The Netherlands - QIAGEN N.V. announced that it has launched a series of off-the-shelf human library siRNA sets, covering a broad gene family selection including kinases, GPCRs, apoptosis related genes, and oncogenes, to name a few. All siRNA designs were accomplished using the ...
'Gene Silencing' Licence Boosts Crop Research
28-04-2004
Canberra, Australia. CSIRO has entered into a landmark licence agreement with Bayer CropScience over the application of its DNA-delivered RNAi (RNAi) gene silencing technology in certain major crops. The deal is the first licence of CSIRO's patented RNAi technology to a leading ...
Benitec Initiates Patent Infringement Lawsuit
29-03-2004
Queensland. Benitec Ltd announced that it initiated patent infringement lawsuits in the United States District Court for the District of Delaware against Nucleonics, Inc., Ambion, Inc., and Genscript Corporation to protect its gene silencing technologies. The lawsuit alleges that the three ...
Netmeeting
